ENGOT-EN2/GEICO 47-E (A Santaballa)
A Phase III trial of postoperative chemotherapy or no further treatment for patients with node negative stage I/II intermediate or high-risk endometrial cancer.
ENGOT-EN3/GEICO 64-E/PALEO (C Mendiola)
A phase II trial of Palbociclib in combination with Letrozole versus Letrozole Monotherapy for patients with Estrogen Receptor Positive advanced or recurrent Endometrial cancer.
GEICO 59-RT/Retro LMS (MJ Rubio)
Yondelis in uterine leiomyosarcoma: retrospective study + biomarkers.
Phase IV-II trial of Temozolomide in a continuous oral administration schedule in the treatment of Gynaecological Sarcomas.